Key result
Clinical management of obesity-hypertension is complicated by intertwined pathophysiological mechanisms and inadequate obesity therapies, though standard antihypertensive drugs remain applicable.
Why the study?
Fundamental and clinical knowledge of obesity-hypertension and its treatment remains relatively meager and inadequate despite years of investigation.
Answers are grounded in this paper and cite their sources.
This review highlights the complex pathophysiology of obesity-hypertension and discusses clinical management using lifestyle modifications and antihypertensive therapies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Edward D. Fröhlich (2002) conducted a review in Obesity-hypertension. Clinical management (lifestyle modifications and antihypertensive therapy) was evaluated. Clinical management of obesity-hypertension is complicated by intertwined pathophysiological mechanisms and inadequate obesity therapies, though standard antihypertensive drugs remain applicable.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: